Basal insulin and glucagon-like peptide 1 receptor agonist (GLP1-RA) combination

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 3

Abstract

Diabetes mellitus is a chronic disease affecting more than 425 million people worldwide. Patients with type 2 diabetes frequently do not reach HbA1c targets. Historically insulin has been viewed as the most effective glucose-lowering agent in poorly controlled type 2 diabetes. When therapeutic intensification beyond basal insulin plus oral agents is required, adding a bolus, or prandial, rapidacting insulin analog has been recommended either in a stepwise approach or as a full basal-bolus in¬sulin regimen. Adding a GLP-1 receptor agonist to basal insulin may be as effective as adding prandial insulin therapy. Two products, an insulin degludec/liraglutide combination (IDegLira) and an insulin glargine/lixisenatide combination (IGlarLixi), ARE approved for use in adults with T2DM. The efficacy and safety of these two basal insulin/GLP-1RA combination products have been studied in the DUAL program and Laxilan program. Clinical trial data has showed insulin/GLP-1RA fixed-ratio combinations are superior at reducing HbA1c with weight neutrality or weight loss rather than weight gain, as well as reduced hypoglycemia rates compared with basal insulin highlighting the great potential of these agents.

Authors and Affiliations

Sandeep Chaudhary, Khalid Shaikh

Keywords

Related Articles

Antimicrobial coated sutures in Indian Market : A literature review of efficacy and safety in patients to prevent surgical site infections

Surgical suture material is used to adequately adapt the wound edges. To prevent microbial colonization of the suture material in operative incisions, sutures with antibacterial activity have been developed. In India, tr...

Our experience of civilian bullet injuries of dorsal region a series of three cases

Penetrating spine injury (PSI) forms the third most common cause of spine injury, only next to road traffic accidents and fall. Gunshot wound (GSW) forms the major bulk of PSI1.Due to easy availability of firearms and an...

Cardiology : The Emerging Perspective

Cardiology has come a long way since the days of our residency when Lasix, Lanoxin, oxygen and nitrates was the only drugs available to permuteor combine with and watchful expectancy of a recovery were the only option. T...

Refractory diabetes : a 5D approach

This communication shares a simple and pragmatic approach to evaluate and to defect refractory diabetes which does not “respond” to insulin. The 5D rubric offers a mnemonic based best treatment practices in the easiest w...

Acute respiratory distress syndrome : a tale of the sinking lungs

Acute Respiratory distress syndrome (ARDS) is the most devastating inflammatory lung condition associated with high mortality. ARDS is triggered by injury to the alveolo-capillary membrane from a variety of insults resul...

Download PDF file
  • EP ID EP611948
  • DOI -
  • Views 171
  • Downloads 0

How To Cite

Sandeep Chaudhary, Khalid Shaikh (2018). Basal insulin and glucagon-like peptide 1 receptor agonist (GLP1-RA) combination. Journal of the Indian Medical Association, 116(3), 50-54. https://europub.co.uk/articles/-A-611948